Aledade, launched by former national coordinator for health information technology Farzard Mostashari, MD, is looking to expand its footprint throughout the United States to another 7 states in 2016.
Aledade, launched by former national coordinator for health information technology Farzard Mostashari, MD, is looking to expand its footprint throughout the United States to another 7 states.
The company, which partners with independent primary care physicians to help them create and run accountable care organizations (ACOs), currently is present in 4 states: New York, Maryland, Delaware, and Arkansas. In June, Aledade raised $30 million in Series B funding, and now it has applied to CMS to establish new ACOs in 7 states beginning January 1, 2016.
In 2016, the company will create new ACOs in Florida, Kansas, Louisiana, Mississippi, Tennessee, Virginia, and West Virginia. With ACOs in 11 states, Aledade would cover more than 80,000 Medicare beneficiaries while working with more than 100 practices.
The funding raised in June will support this expansion throughout the US, which Dr Mostashari told AJMC.com at the time.
“Two months ago, we vowed to put our new funding to work by expanding our ACO partnership model to independent primary care physicians across the country,” Dr Mostashari said in a statement. “Today, we are taking another step to fulfill that promise—and to deliver high-quality, value-based care to doctors and patients across the country. We’ve been working with practices in these states for months, and we’re already seeing the power of placing independent primary care doctors at the center of their patients’ care.”
In a Web-based session of The American Journal of Managed Care’s ACO and Emerging Healthcare Delivery Coalition held in June, Travis Broome, MPH, MBA, healthcare policy lead at Aledade, explained that the ACO model is even more timely and pertinent today given CMS’ announced timeline to move to value-based payments and the legislation repealing the sustainable growth rate formula that gives physicians a 5% bonus for participating in alternative Medicare payment models like ACOs.
Each of the new ACOs established by Aledade will be led by a dedicated executive director from the company, who will work with a local physician partner as medical director.
“Partnering with Aledade gives us the capital, tools, and expertise to succeed in the new health care environment, and be rewarded for keeping patients healthy,” Jennifer Brull, MD, who will act as the medical director of Aledade’s Kansas ACO, said. “We’ve already been working with the Aledade team for months, and we can’t wait for official CMS recognition.”
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Commonwealth Fund Report Details Pervasive Racial and Ethnic Disparities in US Health Care, Outcomes
April 18th 2024Using 25 health system performance indicators, the Commonwealth Fund 2024 State Health Disparities Report evaluated racial and ethnic disparities in health care and health outcomes both within and across US states and highlighted the urgent need for equitable health care policies and practices in the US.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
The Biden administration recently launched the Global Health Security Strategy, a new effort to combat the spread of infectious diseases; lawmakers zeroed in on the risks of massive consolidation in health care during the first congressional hearing on the Change Healthcare hack; the FDA recently announced the recall of a pair of heart devices linked to numerous deaths and injuries.
Read More
Need for Pharmacogenomic Testing in Mental Health Care Explored at AMCP 2024
April 17th 2024Presenters from Mayo Clinic discussed the benefits of implementing pharmacogenomic testing in mental health care for the betterment of patient outcomes, reducing medical costs, and more at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting.
Read More